/ZIMV
ZIMV Stock - ZimVie Inc.
Healthcare|Medical - DevicesNASDAQ
$18.99+0.00%
+$0.00 (+0.00%) • Oct 20
38
GoAI Score
GoAI Score
Weighted average: Momentum (25%) + Sentiment (35%) + Risk (20%) + Value (20%). ≥70 = BUY, ≤35 = SELL.HOLD
Medium Confidence
Momentum
Momentum Score
Based on price vs 50-day MA (40%), 200-day MA (40%), and MA crossover (20%). Higher = stronger uptrend.81
Sentiment
Sentiment Score
Based on analyst price target upside. 50 = neutral, 100 = very bullish (25%+ upside expected).0
Risk Score
Risk Score
Based on stock beta (volatility). Higher score = lower risk. Red (<40) = high volatility, Green (>60) = stable.38
Price Target
Price Target
Average analyst price target from the last quarter. Shows expected upside/downside from current price.+-47.3%upside
Target: $10.01
AI Analysis PreviewPremium
Real-time AI-powered market analysis
Precise entry/exit price targets
Risk assessment & position sizing
Unlock GoAI Insights for ZIMV
Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.
Buy/Sell Signals
94% win rate on Alpha signals
Deep Analysis
Institutional-grade thesis
Real-Time Alerts
SMS & push notifications
Risk Scoring
Multi-factor analysis
Free 14-day trial • No credit card required
Active Trade Setup
ENTRY ZONE$18.80 – $19.18
TARGET (TP)$10.00
STOP LOSS$17.47
RISK/REWARD1:-5.9
Premium members get real-time SMS alerts
Price Chart
Financial Statements
Revenue & Profitability Trend
← Swipe to see more →
Revenue
Net Income (Profit)
Net Loss
Key Metrics
Market CapN/A
P/E RatioN/A
Beta2.06
52W High$19.01
52W Low$8.15
Avg VolumeN/A
Income Statement (Fiscal Year)
| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Revenue | $449.75M | $457.43M | $913.86M | $1.01B | $912.40M |
| Gross Profit | $287.45M | $290.38M | $613.08M | $628.80M | $599.50M |
| Gross Margin | 63.9% | 63.5% | 67.1% | 62.0% | 65.7% |
| Operating Income | $-20,664,000 | $-30,939,000 | $-50,849,000 | $-73,600,000 | $-67,100,000 |
| Net Income | $-25,825,000 | $-393,282,000 | $-63,881,000 | $-95,300,000 | $-179,000,000 |
| Net Margin | -5.7% | -86.0% | -7.0% | -9.4% | -19.6% |
| EPS | $-0.94 | $-14.87 | $-2.45 | $-3.65 | $-6.86 |
Company Overview
ZimVie Inc., a medical technology company, develops, manufactures, and delivers a portfolio of products and solutions designed to treat a range of spine pathologies, and support dental tooth replacement and restoration procedures worldwide. It offers dental implant systems, prosthetic and abutment products, surgical instrumentation, and kits; bone grafts, barrier membranes, allografts, and collagen wound care products; intraoral scanners; and virtual treatment planning services, guided surgery solutions, CAD/CAM workflow systems, and patient-specific restorative components and intra-oral scanners, as well as spinal fusion implants and instrumentation for various spinal procedures, biologics, and bone healing technologies. The company also provides MIS solutions, such as Vital MIS and Timberline; and motion preservation solutions, including Mobi-C and The Tether. ZimVie Inc. was incorporated in 2021 and is headquartered in Westminster, Colorado.
Visit WebsiteRating Distribution
Strong Buy
0%
Buy / Outperform
2
29%
Hold / Neutral
5
71%
Sell / Underperform
0%
Analyst Consensus🔴 Bearish
2 Bullish5 Neutral/Bearish
Price Targets
$17
Average Target
↓ 9.6% Downside
Now
$9
Low
$17
Average
$20
High
Based on 6 analysts
Recent Analyst Actions
| Date | Firm | Action | Rating | Price Target |
|---|---|---|---|---|
| July 31st 2025 | B. Riley Securities | Downgrade | Neutral | $19 |
| July 22nd 2025 | Barclays | Upgrade | Equal Weight | $19 |
| April 10th 2025 | B. Riley Securities | Initiation | Buy | $16 |
| March 13th 2025 | Needham | Downgrade | Hold | - |
| May 16th 2024 | Needham | Upgrade | Buy | $20 |
| November 16th 2023 | Needham | Initiation | Hold | - |
| December 21st 2022 | Barclays | Initiation | Underweight | $9 |
| June 17th 2022 | JP Morgan | Initiation | Neutral | $20 |
Earnings History & Surprises
ZIMVBeat Rate
69%
Last 16 quarters
Avg Surprise
+93.1%
EPS vs Estimate
Beats / Misses
11/5
Last 12 quarters
Latest EPS
$0.12
Q4 2025
EPS Surprise History
Q1 24
-23.1%
$0.10vs$0.13
Q2 24
+300.0%
$0.08vs$0.02
Q3 24
-23.5%
$0.13vs$0.17
Q4 24
+71.4%
$0.12vs$0.07
Q1 25
+3.8%
$0.27vs$0.26
Q2 25
+28.6%
$0.27vs$0.21
Q3 25
+25.0%
$0.26vs$0.21
Q4 25
-29.4%
$0.12vs$0.17
Beat Estimate
Missed Estimate
Quarterly EPS Details
| Period | Report Date | Estimated EPS | Actual EPS | Surprise | Result |
|---|---|---|---|---|---|
Q4 2025 | Oct 29, 2025 | $0.17 | $0.12 | -29.4% | ✗ MISS |
Q3 2025 | Jul 30, 2025 | $0.21 | $0.26 | +25.0% | ✓ BEAT |
Q2 2025 | May 8, 2025 | $0.21 | $0.27 | +28.6% | ✓ BEAT |
Q1 2025 | Feb 26, 2025 | $0.26 | $0.27 | +3.8% | ✓ BEAT |
Q4 2024 | Oct 30, 2024 | $0.07 | $0.12 | +71.4% | ✓ BEAT |
Q3 2024 | Aug 1, 2024 | $0.17 | $0.13 | -23.5% | ✗ MISS |
Q2 2024 | May 8, 2024 | $0.02 | $0.08 | +300.0% | ✓ BEAT |
Q1 2024 | Feb 28, 2024 | $0.13 | $0.10 | -23.1% | ✗ MISS |
Q4 2023 | Nov 1, 2023 | $0.01 | $0.08 | +490.4% | ✓ BEAT |
Q3 2023 | Aug 2, 2023 | $0.03 | $0.17 | +580.0% | ✓ BEAT |
Q2 2023 | May 3, 2023 | $0.06 | $0.25 | +354.5% | ✓ BEAT |
Q1 2023 | Mar 1, 2023 | $0.28 | $0.16 | -42.9% | ✗ MISS |
Q4 2022 | Nov 9, 2022 | $0.27 | $0.49 | +81.5% | ✓ BEAT |
Q3 2022 | Aug 10, 2022 | $0.51 | $0.67 | +31.4% | ✓ BEAT |
Q2 2022 | May 5, 2022 | $0.38 | $0.50 | +32.6% | ✓ BEAT |
Q1 2022 | Mar 31, 2022 | $0.80 | $-2.33 | -390.7% | ✗ MISS |
Q1 2022 | Feb 22, 2022 | — | $-1.16 | — | — |
Q2 2021 | Jun 30, 2021 | — | $-0.18 | — | — |
Q1 2021 | Mar 31, 2021 | — | $0.02 | — | — |
Q4 2020 | Dec 31, 2020 | — | $1.40 | — | — |
Frequently Asked Questions about ZIMV
What is ZIMV's current stock price?
ZimVie Inc. (ZIMV) is currently trading at $18.99 per share. The stock has moved +0.00% today.
What is the analyst price target for ZIMV?
The average analyst price target for ZIMV is $10.00, based on 1 analyst.
What sector is ZimVie Inc. in?
ZimVie Inc. operates in the Healthcare sector, specifically within the Medical - Devices industry. The company is traded on the NASDAQ exchange.
What is ZIMV's market cap?
ZimVie Inc. has a market capitalization of $0.54 billion, making it a small-cap company.
Does ZIMV pay dividends?
No, ZimVie Inc. does not currently pay a dividend to shareholders.
Similar Stocks
Healthcare SectorACCD
Accolade, Inc.
$7.02
Mkt Cap: $0.6B
APEN
Apollo Endosurgery, Inc.
$10.00
Mkt Cap: $0.6B
BDSI
BioDelivery Sciences International, Inc.
$5.59
Mkt Cap: $0.6B
GRALV
GRAIL, Inc. Common Stock
$18.63
Mkt Cap: $0.6B
IVVD
Invivyd, Inc.
$2.30
Mkt Cap: $0.3B
RGLS
Regulus Therapeutics Inc.
$8.16
Mkt Cap: $0.6B
SAGE
Sage Therapeutics, Inc.
$8.68
Mkt Cap: $0.5B
SHCR
Sharecare, Inc.
$1.43
Mkt Cap: $0.5B
SPRY
ARS Pharmaceuticals, Inc.
$10.49
Mkt Cap: $1.0B
SVA
Sinovac Biotech Ltd.
$6.47
Mkt Cap: $0.5B
Explore stocks similar to ZIMV for comparison